All stock lists
Mentari Therapeutics, Inc. (NASDAQ:MTRI)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$19.10+$0.75 (+4.09%)
Market cap
$10.5M
Insider Score
Health Score
Analyst consensus
Listed since
May 5, 2014
Website
Insider Score
49/ 100
MTRI Insider Score
Neutral16 qualifying trades · 1 insider · $238.37K bought in the last 90 days
MTRI analyst forecast
No analyst ratings in the last 12 months
No independent sell-side analyst publishes on MTRI that our data provider carries. That is normal for smaller listings, and it is not a judgement on the company. Here is what we track instead:
- Insider activity and the Insider Score — what the people who run the company are doing with their own money.
- Promoter Scores — any disclosed paid stock promotion on this ticker.
Best analysts covering MTRI
Every firm covering MTRI has a measured record, but none of them has a Buy or Sell on it from the last 12 months — only a Hold, which is not a directional call and is left out of the ranking.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
MTRI earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-11 | $0.00 | -$0.51 | $0 | $1.1M |
| 2026-05-11 | -$944.44 | -$0.69 | $0 | $1.3M |
| 2026-09-09 | -$944.44 | -$14.30 | $0 | $2.06B |
| 2026-11-03 | -$94.44 | -$3.60 | $300K | $0 |
| 2027-02-10Upcoming | -$0.41 | — | $300K | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.